ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, providing promising developments throughout different healthcare and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, extra reputable substitute for therapeutic use